基于系统的洞察力,对查加斯病的寄生虫学和临床治疗失败
Luis Ernst1, Giovana C Macedo1, Laura-Isobel McCall1
1Department of Chemistry and Biochemistry, San Diego State University, San Diego, California, USA.
mSystems
|January 8, 2025
概括
查加斯病的治疗失败源于耐药性,改变宿主免疫力和组织损伤. 需要新的策略来克服持久性寄生虫和炎症,以有效治疗传染病.
科学领域:
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 查加斯病治疗的成功涉及症状解决 (临床成功) 和病原体清除,但面临着重大挑战.
- 治疗失败可能由各种因素引起,包括耐药性,宿主免疫反应和组织损伤,影响临床结果.
- 了解这些失败机制对于开发有效治疗这种被忽视的热带疾病至关重要.
研究的目的:
- 对查加斯病临床和寄生虫学治疗失败机制的当前知识进行审查.
- 确定当前治疗选择的局限性,并探索新的治疗策略.
- 突出OMIC分析在理解和应对治疗挑战中的作用.
主要方法:
- 文献综述总结了关于查加斯病治疗失败的现有研究.
- 分析导致临床和寄生虫治疗失败的因素.
- 讨论过去,现在和未来的治疗方法.
主要成果:
- 查加斯病治疗失败的主要原因包括寄生虫的耐药性/持久性,药物药理动力学/动力学,以及改变宿主免疫反应/组织损伤.
- 几种治疗方法未能获得监管部门的批准,目前的选择有局限性.
- 持续的寄生虫,炎症和代谢变化是重要的障碍.
结论:
- 解决沙加斯病治疗失败需要解决寄生虫的持久性,宿主免疫失调和组织损伤.
- 新的治疗策略对于克服当前治疗方法的局限性至关重要.
- 大规模的奥米克分析对于推进查加斯病药物治疗和未来研究至关重要.
相关概念视频
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...